Animal Wound Care Market worth $1.5 billion by 2025 - Exclusive Report by MarketsandMarkets™9/16/2021 According to the new market research report "Animal Wound Care Market by Product (Surgical (Suture, Sealant, Glue) Advanced (Film, Foam, Hydrogel, Hydrocolloid dressing) Traditional (Dressing, Bandage, Absorbent, Tape) & NPWT Device) Animal (Companion, Livestock) & End User - Global Forecast to 2025", published by MarketsandMarkets™, the Animal Wound Care Market is projected to reach USD 1.5 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 7.4% during the forecast period.
Browse in-depth TOC on "Animal Wound Care Market" 192 – Tables 35 – Figures 228 – Pages Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253831778 The rising demand for animal food products, increasing concerns over animal diseases, growing companion animal market, and surging veterinary healthcare expenditure are the major factors driving the growth of this market. However, an increase in pet care costs, low adoption of advanced animal wound care products in emerging markets, and shortage of vet practitioners in developing markets are hindering the market's growth. Growing pet population and rising pet expenditure to drive the demand for surgical wound care products. Based on product, the animal wound care market is segmented into surgical wound care products, advanced wound care products, traditional wound care products, and therapy devices. Surgical wound care products accounted for the largest share in 2019. The large share of this segment can primarily be attributed to the increasing number of animal conditions requiring surgeries, rising adoption of surgical wound care products in veterinary practices and increasing pet adoption and pet care expenditure. Increasing adoption of companion animal is expected to drive its market growth. Based on animal type, animal wound care market is segmented into companion animal and livestock animals. In 2019, companion animals accounted for the largest share of the global market. The growth of this segment can be attributed to the growing companion animal population, increasing pet care expenditure, rising number of sports horses, and surging demand for pet insurance across the world. The hospitals segment accounted for the largest market share in 2019 Based on end user, the market is segmented into veterinary hospitals & clinics, and home care settings. Veterinary hospitals & clinics accounted for the largest share of the market in 2019. The large share of this segment can be attributed to growing awareness about animal health, increasing companion animal population, and rising pet care expenditure in emerging regions. Get 10% Customization on this Research Report :-https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=253831778 North America was the largest regional market for animal wound care market in 2019 The market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latina America, and the Middle East and Africa. In 2019, North America accounted for the largest share. North America's prominence in this market is mainly attributed to the increasing population of companion animals and growing pet care expenditure. The market in Asia Pacific is expected to grow at the highest CAGR during the forecast period. This can be attributed to the rising population of livestock animals, increasing consumption of animal-derived food products, and growing adoption of pets. The prominent players in the global animal wound care market are Elanco Animal Health (US), Medtronic PLC (Ireland), B Braun Melsungen AG (Germany), 3M Company (US), Virbac (France), Jorgen Kruuse A/S (Denmark), Dechra Pharmaceuticals (UK), Neogen Corporation (US), Ethicon, Inc. (US), Sonoma Pharmaceuticals Inc. (US), Jazz Medical, LLC (Ireland), Smith & Nephew PLC (UK), and Kericure Inc. (US). Browse Related Reports: Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) - Global Forecast to 2026https://www.marketsandmarkets.com/Market-Reports/animal-antimicrobials-antibiotics-market-25161353.html Animal Growth Promoters and Performance Enhancers Market by Product Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probioitcs & Prebiotics, Phytogenics), Animal (Poultry, Porcine, Livestock, Aquaculture) - Global Forecast to 2024https://www.marketsandmarkets.com/Market-Reports/animal-growth-promoters-performance-enhancers-market-137134167.html
0 Comments
According to the new market research report "Pharmaceutical Membrane Filtration Market by Product (Filter, System), Technique (Microfiltration, Nanofiltration), Material (PES, PVDF, PTFE), Application (Final Product (Sterile Filtration), Raw Material, Cell Separation, Water) - Global Forecast to 2025", published by MarketsandMarkets™, the global Pharmaceutical Membrane Filtration Market is expected to grow from USD 5.8 billion in 2020 to USD 10.2 billion by 2025, at a CAGR of 12.0% from 2020 to 2025.
Browse in-depth TOC on "Pharmaceutical Membrane Filtration Market" 326 – Tables 36 – Figures 248 – Pages Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255408031 The major factors driving the growth of this market are the increasing adoption of single-use technologies and the growing demand for nanofiltration. Geographical expansion in countries such as Singapore, France, China, and India and the demand for polyamide track-etched membranes in ultrafiltration are likely to provide growth opportunities for players in the market. Filters segment accounted for the largest share of the pharmaceutical membrane filtration market, by product, in 2019 On the basis of product, the market is segmented into filters, systems, and accessories. Filters formed the largest product segment in this market owing to the high and growing use of different types of membrane filters for various filtration applications in the biopharmaceutical manufacturing industry. Final product processing segment accounted for the largest share of the pharmaceutical membrane filtration market, by application, in 2019 On the basis of application, the market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification. Final product processing was the largest application segment in the market in 2019. The increasing production of generics, rapid growth in the biopharmaceutical industry, and the increasing adoption of membrane filters in protein purification, sterile filtration, and viral clearance processes are the major factors driving the growth of this application segment. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=255408031 In 2019, North America was the largest regional market for pharmaceutical membrane filtration The global pharmaceutical membrane filtration market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest market for pharmaceutical membrane filtration, followed by Europe. The large share of North America can be attributed to several factors, such as the presence of key biopharmaceutical manufacturing facilities in the region and the significant spending on research and development activities in the US. The major companies operating in the pharmaceutical membrane filtration market include Merck (Germany), Danaher (US) and Sartorius Stedim Biotech (France). Browse Related Reports: Hollow Fiber Filtration Market by Material (Polymer (PES, PVDF), Ceramic), Technique (Microfiltration, Ultrafiltration), Application (Harvest & Clarification, Concentration, Diafiltration), End Users (Pharma, Biotech, CRO, CMO) - Global Forecast to 2026https://www.marketsandmarkets.com/Market-Reports/hollow-fiber-filtration-market-267011039.html Pharmaceutical Filtration Market by Product (Membrane Filters, Single-Use Systems), Technique (Microfiltration, Ultrafiltration), Application (Final Product Processing, Raw material), Scale of Operation (Manufacturing, Pilot, R&D) - Global Forecast to 2021https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-filtration-market-209343847.html According to the new market research report " Medical Device Outsourced Manufacturing Market by Device Type (IVD (Equipment, Consumable), Diabetes, Respiratory, Cardiovascular, Personal Care, Endoscopy, Dental, Ophthalmology, Devices) Class of Device, Services, Procedure - APAC Forecast to 2026", published by MarketsandMarkets™, the APAC Medical Device Outsourced Manufacturing Market is projected to reach USD 56.2 billion by 2026 from USD 29.3 billion in 2021 and is expected to grow at a CAGR of 13.9% during the forecast period. Browse in-depth TOC on "Medical Device Outsourced Manufacturing Market" 200 – Tables 61 – Figures 306 – Pages Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=477468 The Asia Pacific market is mainly driven by the overall growth of the medical devices market, mainly due to the rising disease prevalence, life expectancy, and geriatric population. Technological advancements have prompted end users to overhaul or update their manufacturing systems. As this is a costly process, they look to outsource contract manufacturing. However, market growth is impeded by the growing consolidation in the medical devices market. To develop their own manufacturing capabilities and save costs, Larger players are focusing on acquiring smaller players and CMOs themselves. This may affect the overall market growth to a certain extent. The IVD devices segment accounted for the largest share of Asia Pacific medical device outsourced manufacturing market in 2020 Based on device type, the Asia Pacific market is broadly segmented into IVD devices, diagnostic imaging devices, cardiovascular devices, drug delivery devices, orthopedic devices, respiratory care devices, ophthalmology devices, surgical devices, diabetes care devices, dental devices, endoscopy devices, gynecology/urology devices, personal care devices, neurology devices, and other devices. In 2020, the IVD devices segment accounted for the largest share of the Asia Pacific market. The large share of this segment can be attributed to the increasing volume of IVD tests performed globally, increasing availability of IVD kits and reagents in the market, a growing number of hospitals and clinical laboratories in developing countries, automation and technological advancements in instruments with high-throughput capabilities, high demand for IVD tests in the COVID-19 pandemic, and advances in life science research. Class II medical devices segment accounted for the largest share of APAC market in 2020. Based on the class of device, the medical device outsourced manufacturing market is segmented into Class I, Class II, and Class III medical devices. In 2020, the Class II medical devices segment accounted for the largest share of the Asia Pacific market. The large share of this segment can be attributed to the large number of medical devices outsourced that fall under this device class and the utilization of a higher volume of these devices by end users and caregivers in the healthcare industry. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=477468 In 2020, device development and manufacturing services segment accounted for the largest share of the Asia Pacific market Based on service, the Asia Pacific medical device outsourced manufacturing market is segmented into device development and manufacturing services, quality management services, packaging and assembly services and other services. In 2020, the device development and manufacturing services segment dominated this market. The increasing adoption of contract manufacturing services in the medical device industry, growth in the medical devices market (especially in the single-use disposable medical devices market), and improving device development and manufacturing capabilities are the major factors responsible for the large share of this segment. In 2020, production segment accounted for the largest share of Asia Pacific medical device outsourced manufacturing market Based on process, the Asia Pacific market is broadly segmented into production, prototyping, pilot production, design for manufacturing, process evaluation, validation, project management, packaging, and assembly. In 2020, the production segment accounted for the largest share of the market. The large share of this segment can be attributed to the growing number of medical device companies outsourcing their production tasks to minimize manufacturing costs. China is expected to witness fastest growth during the forecast period of 2021–2026. The Asia Pacific medical device outsourced manufacturing market, by country, has been segmented into China, Japan, Malaysia & Singapore, India, Australia & New Zealand, South Korea, and the Rest of APAC. China is expected to witness fastest growth during the forecast period of 2021–2026. China's fastest growth is mainly due to the lower cost of raw materials and labor in the country than in developed countries. The increasing demand for medical devices due to improving healthcare infrastructures, adoption of technologically advanced products, and increasing awareness of diagnosis are also expected to drive the growth of this market. The prominent players in this medical device outsourced manufacturing market are Flex, Ltd. (Singapore), Jabil, Inc. (US), TE Connectivity, Ltd. (Switzerland), Sanmina Corporation (US), Nipro Corporation (Japan), Celestica International (Canada), Plexus Corporation (US), Benchmark Electronics, Inc. (US), Integer Holdings Corporation (US), Gerresheimer Ag (Germany), West Pharmaceutical Services, Inc. (US), Nortech Systems, Inc. (US), Consort Medical PLC (UK), Kimball Electronics Inc. (US), and Teleflex Incorporated (US), Nordson Corporation (US), Tecomet, Inc. (US), SMC Ltd. (US), Nemera (France), and Tessy Plastics Corporation (US), among others. Browse Related Reports: In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html According to the new market research report "High-Throughput Screening (HTS) Market by Product (Instruments, Software, Service), Technology (Cell-Based Assays, Label-Free), Application (Drug Discovery, Biochemical Screening, Research), End User (Pharma & Biotech, CROs)- Global Forecast to 2025", published by MarketsandMarkets™, the global High-Throughput Screening Market size is projected to reach USD 26.4 billion by 2025 from USD 15.3 billion in 2020, at a CAGR of 11.5% during the forecast period.
Browse in-depth TOC on "High-Throughput Screening (HTS) Market" 432 – Tables 40 – Figures 319 – Pages Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950 The HTS Market growth is driven mainly by factors such as increasing R&D spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput screening market and the availability of government funding & venture capital investments. Emerging markets and growing applications in life sciences research are also factors expected to provide growth opportunities for players in the market. The consumables segment accounted for the largest share of the product & services segment in the high-throughput screening market in 2019. On the basis type of product & service, the HTS Market is broadly segmented into consumables , instruments, services, and software. In 2019, consumables accounted for the largest share of the high-throughput screening (HTS) market. This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R&D, and rising government funding for life sciences research. The drug discovery segment accounted for the largest share of the application segment in the high-throughput screening market in 2019. Based on application, the HTS Market is categorized into four segments—drug discovery, biochemical screening, life sciences, and other applications. The drug discovery application segment accounted for the largest share of the market in 2019. The key factor driving this segments growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure. Request Sample Pages:-https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950 The Asia Pacific region is the fastest-growing region of the high-throughput screening market in 2019. In 2019, Asia Pacific region accounted for the fastest-growing region of the HTS Market. It is also estimated to grow at the highest CAGR in the market during the forecast period, this is mainly due to factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the market in this region. Some of the prominent players in the high-throughput screening market are Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Group Ltd. (Switzerland), AXXAM S.p.A. (Italy), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Corning Incorporated (US), and Eurofins Scientific (Luxembourg). Browse Related Reports: Cell Analysis Market by Product [Microscope, Spectrophotometers, Flow cytometry (Software, Accessories)], Process (Cell Viability, Cell Proliferation, Signal Transduction), End User (Pharma, Research, Biotechnology Companies) - Global Forecast to 2024https://www.marketsandmarkets.com/Market-Reports/cell-analysis-market-157543946.html According to the new market research report " Chromatography Instruments Market by Type (Liquid Chromatography, Gas Chromatography), Consumable & Accessory (Columns, Detectors, Pressure Regulators), End User (Life Science Industry, Oil & Gas Industry), and Region - Analysis & Global Forecasts to 2025", published by MarketsandMarkets™, the Chromatography Instruments Market is expected to reach USD 11.0 billion by 2025 from USD 8.6 billion in 2020, at a CAGR of 5.1%.
Browse in-depth TOC on "Chromatography Instruments Market" 141 – Tables 33 – Figures 248 – Pages Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1258 The growing investments in the pharmaceutical R&D, rising food safety concerns, increasing adoption of gas chromatography in oil & gas industry and policies to reduce environmental pollution levels are the key drivers of the chromatography instruments market growth. Increasing burden on healthcare systems owing to the COVID-19 pandemic worldwide and growing importance of chromatography tests in drug approval process will further upsurge the demand for chromatography instruments. The chromatography instruments market includes Tier I and II vendors like Agilent Technologies, Shimadzu Corporation, Waters Corporation, Thermo Fisher Scientific and PerkinElmer among others. The companies have a large market spread across various countries in North America, Europe, Asia Pacific and Rest of the World. The global COVID-19 outbreak has impacted the business to a certain extent as multiple manufacturing facilities of players were shut down during the lockdown. Despite of the challenging situation, industries are gradually recovering from the impact of the pandemic. As the supply and distribution channels are beginning to open up, business operations are likely to rise at a slow and steady rate in the near future. Thus, the pandemic is not estimated to have long-term effects on the fundamental growth drivers of the chromatography instruments market. It is estimated that market reconciliation and development would be seen toward the beginning of 2021. Liquid chromatography systems segment is anticipated to be the fastest growing segment during the forecast period The market is segmented by type, into liquid chromatography (LC) systems, gas chromatography (GC) systems, supercritical fluid chromatography (SFC) systems and thin-layer chromatography (TLC) systems.. The liquid chromatography systems segment is estimated to command the largest share of the market in 2020, and is projected to register the highest CAGR during the forecast period. Increasing demand for liquid chromatography systems in pharma and biotech industries along with growing adoption of gas chromtaogrpahy systems in oil & gas industries is expected to boost the market growth during the forecast period. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=1258 Columns, that form the most important part of the chromatography systems, are expected to command the largest market share in 2020 The chromatography instruments market, by consumable & accessory is broadly segmented into column, column accessories, autosampler, autosampler accessories, flow management accessories, solvents/reagents/adsorbents, chromatography fittings and tubing, detectors, mobile phase accessories, fraction collectors, pressure regulators, and other accessories. The columns segment is expected to occupy large market share owing to the importance of columns in the chromatography systems, as chromatographic separation takes place inside the column. Additionally, growing importance of chromatography tests in drug development, will subsequently upsurge the demand for such chromatography consumables and accessories. Life science industry to witness highest growth during the forecast period The end-user industry is segmented into life science industry, academic & research institutes, oil & gas industry, environmental agencies, food & beverage industry and other end user industries. The life science industry is expected to hold the largest share of the market in 2020 owing to the increasing R&D investment by pharmaceutical & biotechnology companies. This end-user segment is expected to grow rapidly in the coming years due to the use of chromatography in various research applications, bulk drug manufacturing, stabilization of drugs, and qualitative and quantitative pharmaceutical analysis. The North America chromatography instruments market to hold the largest market share in 2020 North America is expected to dominate the global market in 2020, followed by Europe, whereas the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high regional growth is attributed to the increasing R&D funding in healthcare industries, growing number of preclinical activities by CROs and pharmaceutical companies, upsurge in the number of metabolomics research studies, growing food and agricultural industry in Canada and presence of developed healthcare and research infrastructure. The major players operating in the chromatography instruments market include Agilent Technologies (US), Waters Corporation (US), Shimadzu (Japan), Thermo Fisher Scientific (US), PerkinElmer (US), Merck KGaA (Germany), Phenomenex (US), Bio-Rad Laboratories (US), Cytiva (US), Hitachi (Japan) and Restek Corporation (US) among others. Browse Related Reports: High-performance Liquid Chromatography (HPLC) Market by Product (Instruments (Systems, Detectors), Consumables (Columns, Filters), and Accessories), Application (Clinical Research, Diagnostics, Forensics), Region - Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/hplc-market-117899209.html Particle Size Analysis Market Worth $465 Million by 2025 - Exclusive Report by MarketsandMarkets™9/8/2021 According to the new market research report " Particle Size Analysis Market by Technology (Laser Diffraction, DLS, Static, Dynamic Imaging, Coulter Principle, Nanoparticle Tracking), Dispersion, End-User (Pharmaceutical, Chemical, Petroleum, Mining, Food, Academia), Region - Global Forecast to 2025", published by MarketsandMarkets™, the Particle Size Analysis Market is projected to reach USD 465 million by 2025 from USD 356 million in 2020, growing at a CAGR of 5.5% during the forecast period.
Browse in-depth TOC on "Particle Size Analysis Market" 77 – Tables 25 – Figures 156 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74084833 Increasing research activities in the field of nanotechnology, rising investments in pharmaceutical R&D, and stringent regulatory guidelines for product quality across industries are fueling the growth of the market. Moreover, increasing government support for nanotechnology research and the rapidly growing pharmaceutical industry in emerging countries are some of the other major factors driving the growth of this market. The laser diffraction segment accounted for the largest share of the particle size analysis market, by technology, in 2019 Based on technology, the market is segmented into laser diffraction, dynamic light scattering, imaging, coulter principle, nanoparticle tracking analysis, and other technologies. The laser diffraction segment accounted for the largest share of the particle size analysis market in 2019, driven by the growing initiatives to create awareness about laser diffraction, increasing R&D expenditure in the pharma and biotech sectors, and rising food safety concerns. Dynamic imaging to dominate the imaging market during the forecast period Based on type, the imaging market is segmented into two major types—dynamic imaging and static imaging. Factors such as high-quality/resolution images, better image recognition, user-friendliness, individual sample measurement, and high-speed analysis are driving the growth of the dynamic imaging segment. Nanoparticle Tracking Analysis (NTA) segment to register the highest growth during the forecast period, by technology The Nanoparticle Tracking Analysis (NTA) segment is expected to register the highest growth during the forecast period by technology. The significant growth of this segment is attributed to advanced applications of these particle size analyzers and growing research activities in the field of nanotechnology. NTA is mainly used in biopharma and biotech applications. Increasing R&D activities in the biopharmaceutical industry are expected to propel the growth of this segment. Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=74084833 The North American region accounted for the largest share of the particle size analysis market in 2019. The particle size analysis industry is segmented into five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The North American region accounted for the largest share of the particle size analysis market in 2019. Presence of a large customer base in the region. relatively low energy prices in the US market as compared to other competitive nations such as the UK and Japan are encouraging the growth of end-use markets (such as mining, minerals, chemicals, petroleum) in the US. Moreover, significant funding for nanotechnology development and strict industrial regulations for particle size analysis for pharmaceutical drugs and food products with respect to drug development and quality control are some of the major factors driving the growth of this market. The major players operating in the particle size analysis market are Malvern Panalytical (UK), HORIBA (Japan), Beckman Coulter, (UK), MICROTRAC MRB, (US), Izon Science (UK), Micromeritics Instrument Corporation (US), Shimadzu Corporation (Japan), Sympatec (Germany), Anton Paar (Austria), TSI (US), Bettersize Instruments (China), FRITSCH (Germany), Brookhaven Instruments, (US), LS Instruments AG (Switzerland), and AimSizer (China). According to the new market research report "Nerve Repair and Regeneration Market by Products (Nerve Conduits, Nerve Wraps, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, TENS, TMS), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) and Region - Global Forecast to 2025", published by MarketsandMarkets™, the global Nerve Repair and Regeneration Market size is projected to reach USD 9.7 billion by 2025 from USD 6.3 billion in 2020, growing at a CAGR of 9.1% from 2020 to 2025.
Browse in-depth TOC on "Nerve Repair and Regeneration Market" 142 – Tables 43 – Figures 167 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=883 The Growth in Nerve Regeneration Market is driven mainly by high incidence of nerve injuries, the growing prevalence of neurological disorders, and rising government support for neurologic disorder research. Neurostimulation and Neuromodulation Devices accounted for the largest share of the market, by product, in 2019 By product, the nerve repair market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment is segment is expected to grow at the highest growth rate during the forecast period. The large market share of this segment is driven mainly by rising government expenditure for neurologic disorders, and favorable reimbursement . By neurostimulation and neuromodulation application, internal neurostimulation and neuromodulation accounted for the largest market share in 2019 Based on the neurostimulation and neuromodulation application , the Nerve Regeneration Market is segmented the neurostimulation and neuromodulation devices market is segmented into internal neurostimulation and neuromodulation applications and external neurostimulation and neuromodulation applications. The internal neurostimulation and neuromodulation segment is estimated to register the highest CAGR during the forecast period. This can primarily be attributed to the increasing incidence of neurological disorders across the globe. By Biomaterials application, direct nerve repair/neurorrhaphy accounted for the largest market share in 2019 Based on application, the biomaterials market is segmented into direct nerve repair/neurorrhaphy, nerve grafting, and stem cell therapy. In 2019, the direct nerve repair segment accounted for the largest share of the market. This can be attributed to the increasing incidence of neurological disorders across the globe. Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=883 North America was the largest regional market for Nerve Repair Market in 2019 The Nerve Repair And Regeneration Market is segmented into five major regions, namely, Europe, North America, the Asia Pacific, Latin America, and Middle East & Africa. In 2019, North America accounted for the largest share of the Nerve Regeneration Market, followed by Europe. The rising incidence of neurological disorders, favorable reimbursement policies, and the strong presence of industry players in the region are the major factors driving the growth of the market in North America. Some of the major players operating in the global Nerve Repair And Regeneration Market include Medtronic, PLC. (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), AxoGen, Inc. (US), Baxter International, Inc. (US), LivaNova, PLC. (UK), Integra LifeSciences (US), Polyganics (Netherlands), NeuroPace, Inc. (US), Soterix Medical, Inc. (US), Nevro Corp (US), Synapse Biomedical, Inc. (US), Aleva Neurotherapeutics (Switzerland), Collagen Matrix, Inc. (US), KeriMedical (Switzerland), BioWave Corporation (US), NeuroSigma (US), tVNS Technologies GmbH(Germany), and GiMer Medical (Taiwan). Browse Related Reports: Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Autoimmune & Inflammatory), Cell Source (Adipose tissue, Bone Marrow, Placenta/Umbilical Cord) - Global Forecasts to 2026 https://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html Ophthalmic Equipment Market worth $63.3 Billion by 2025 - Exclusive Report by MarketsandMarkets™9/6/2021 According to the new market research report "Ophthalmic Equipment Market by Product (OCT, Fundus Camera, Ultrasound, Ophthalmoscope, Phoropter, Slit Lamp, Perimeter, Keratometer, Tonometer, IOL, Excimer Laser, OVDs, Phacoemulsification) End User (Hospital, Consumer) - Global Forecast to 2025", published by MarketsandMarkets™, the market size is projected to reach USD 63.3 billion by 2025 from USD 52.8 billion in 2020, at a CAGR of 3.7% during the forecast period. The rapid growth in the geriatric population, rising prevalence of eye diseases, and technological advancements in ophthalmic devices are the major factors driving the growth of this market.
Browse and in-depth TOC on "Ophthalmic Equipment Market" 391 - Tables 41 - Figures 372 - Pages Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155637364 The vision care products segment is expected for the largest share of the Ophthalmic Equipment Market in 2019. Based on product, the Ophthalmic Equipment Market is categorized mainly into diagnostic & monitoring devices, surgical devices, and vision care products. In 2019, the vision care products segment was expected to account for the largest share of the Ophthalmic Equipment Market. The large share of this segment can primarily be attributed to the high prevalence of eye disorders such as myopia, hyperopia, astigmatism, and presbyopia. In addition to this, technological advancements in lens materials, growing awareness about eyesight correction, and rising trends in eyewear, such as styled sunglasses and advanced contact lenses boasting extra comfort, have further stimulated the adoption of vision care products. By end user, the specialty clinics & ambulatory surgery centers (ASCs) segment is expected to grow at the highest CAGR during the forecast period. Based on end-user, the Ophthalmic Equipment Market is segmented into consumers, hospitals, specialty clinics & ambulatory surgery centers (ASCs), and other end users. specialty clinics & ambulatory surgery centers (ASCs) are expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the rising number of cataract surgeries performed in these facilities due to their cost-effectiveness. Get 10% Customization Research Report: -https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=155637364 North America to hold the largest regional market share in 2019. North America is expected to account for the largest share of the Ophthalmic Equipment Market in 2019, followed by Europe. The large share of North America can be attributed to the rising prevalence of ocular disorders, growth in the geriatric population, increase in healthcare expenditure, and technological advancements in ophthalmic equipment. In addition, factor such as the growing awareness and uptake of ophthalmic treatments and surgeries and the availability of advanced ophthalmic devices in this region are also driving the growth of the Ophthalmic Equipment Market in North America. The prominent players in Ophthalmic Equipment Market are EssilorLuxottica (France), Alcon (US), Johnson & Johnson Vision Care (US), HOYA Corporation (Japan), Bausch + Lomb (US), Carl Zeiss Meditec (Germany), Topcon (Japan), Glaukos Corporation (US), Haag-Streit (Switzerland), NIDEK (Japan), STAAR Surgical (US), Ziemer Ophthalmic Systems (Switzerland), CooperVision, Inc. (US), Oculentis (Germany), Heidelberg Engineering (Germany), Canon (Japan), Optovue (US), Neo Vision (Korea), Lumenis (Israel), Reichert Technologies (US), OPHTEC BV (Netherlands), Heine Optotechnik (Germany), and Luneau Technology (France). Browse Related Reports: Ophthalmic Surgical Instruments Market by Product (Cataracts (IOL, OVD), Refractive (Femtosecond, Excimer Laser) Glaucoma, Vitreoretinal (Vitrectomy Machine & Packs) Surgical Microscope] End User (Hospital, Specialty Clinic) - Global Forecast to 2022https://www.marketsandmarkets.com/Market-Reports/ophthalmic-surgical-instrument-market-11819932.html Ophthalmic Lasers Market by Product Type (Femtosecond Lasers, Excimer Lasers, Nd:YAG Lasers, Diode Lasers, and Other Lasers), Application (Refractive Error Correction, Cataract Removal, Glaucoma Treatment, Diabetic Retinopathy Treatment, AMD Treatment, and Other Applications), & End User (Hospitals and Clinics and Ambulatory Surgery Centers (ASCs) - Global Forecast to 2021 https://www.marketsandmarkets.com/Market-Reports/ophthalmic-laser-market-251971654.html Surgical Robots Market worth $14.4 billion by 2026 - Exclusive Report by MarketsandMarkets™9/5/2021 According to the new market research report "Surgical Robots Market by Product & Service (Instruments & Accessories, Systems, Service), Application (Urological Surgery, Gynecological Surgery, Orthopedic Surgery), End User (Hospitals, Ambulatory Surgery Center) - Analysis and Global Forecasts to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 14.4 billion by 2026 from an estimated USD 6.4 billion in 2021, at a CAGR of 17.6%.
Browse in-depth TOC on "Surgical Robots Market" 212 – Tables 35 – Figures 220 – Pages Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256618532 The Growth in this market is primarily driven by the advantages of robotic-assisted surgery, technological advancements in surgical robots, the increasing adoption of surgical robots, and increased funding for medical robot research. The companies have a large market spread across various countries in North America, Europe, Asia Pacific, and the Rest of the World. The COVID-19 pandemic has had a devastating global impact on the world's population and economy. The pandemic has put a significant strain on healthcare systems. During this period, healthcare institutions and providers have been instructed to stop performing elective surgical procedures and medical examinations to minimize the possibility of transmission and conserve healthcare resources for COVID-19 patients. The pandemic has led to a temporary ban on elective surgeries across the globe, which resulted in the cancellations of elective surgeries worldwide posing a negative impact on the globe. Instruments and Accessories to account for the largest share in the market Based on product & service, the surgical robots market is segmented into robotic systems, instruments & accessories, and services. The instruments & accessories segment commanded the largest share of 53.8% of the market in 2020. This segment is also expected to grow at the highest CAGR of 18.2% during the forecast period. The large share and high growth rate of this segment are mainly driven by the recurrent purchase of instruments & accessories instead of robotic systems, which are a one-time investment. General surgery to account for the fastest growing application in the market Based on application, the surgical robots market is segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications. The general surgery segment commanded the largest share of 29.5% of the market in 2020. This segment is also projected to register the highest CAGR of 18.2% during the forecast period. Growth in this market segment can be attributed to the increased use of surgical robots in general procedures such as bariatric surgery, Heller myotomy, gastrectomy, hernia repair, cholecystectomy, transoral surgery, and pancreatectomy. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=256618532 Asia Pacific to Witness highest growth from 2021 to 2026 North America dominated the surgical robots market, with a share of 63.6% in 2019, while the Asia Pacific region is expected to register the highest CAGR of 18.5% during the forecast period. The large share of the North American market can be attributed to the availability of funding for R&D in surgical robots in this region and the increasing adoption of surgical robots for pediatric surgeries in Canada and general surgery procedures in the US. Some of the prominent players operating in the Surgical robots market are Intuitive Surgical (US), Stryker Corporation (US), Medtronic (Ireland), Smith & Nephew (UK), Zimmer Biomet (US), Asensus Surgical (Transenterix) (US), Corindus Vascular Robotics (US), Renishaw (UK), Auris Health (US), Medrobotics Corporation (US), Think Surgical (US), Verb Surgical (US), OMNIlife Science (US), CMR Surgical (US), Preceyes BV (Netherlands), China National Scientific Instruments And Materials Corporation (CSIMC) (China), Microsure (Netherlands), Titan Medical (Canada), avateramedical Gmbh (Germany) and Medicaroid Corporation (Japan). According to the new market research report "Infusion Pump Market by Product [Accessories (Dedicated, Non-dedicated), Devices (Volumetric, Insulin, Syringe, Ambulatory)], Technology (Traditional, Specialty), Application (Cancer, Diabetes), & Setting (Hospital, Homecare) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is expected to reach USD 20.5 Billion by 2026 from an estimated USD 13.2 Billion in 2021, at a CAGR of 9.3%.
Browse in-depth TOC on "Infusion Pump Market" 374 – Tables 81 – Figures 429 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90374506 The Growth in the market is largely driven by the rising demand for ambulatory infusion pumps in home care, increasing incidence of chronic diseases along with the rapid growth of the geriatric population, growing number of surgical procedures performed, and increasing number of ICU beds in countries with a high prevalence of COVID-19. On the other hand, product recalls, stringent regulatory requirements for new products and increasing adoption of refurbished and rental infusion pumps are expected to restrain the overall market growth. Increasing incidence of medication errors and lack of wireless connectivity in most hospitals is the most common challenge faced by the market. High growth opportunities in emerging countries and growing adoption of specialty infusion systems are the opportunity areas in infusion pump market. The accessories & consumables segment holds the highest CAGR during the forecast period. The accessories & consumables segment is estimated to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the recurrent use of accessories & consumables and the increasing adoption of infusion pumps for the delivery of medications in a controlled environment. Chemotherapy accounted for the highest share for the infusion pump market Based on application the chemotherapy/oncology application segment accounted for the largest share of the market in 2020. The large share of this segment can be attributed to the growing incidence of cancer, increasing availability of ambulatory infusion pumps for chemotherapy, and the introduction of technologically advanced products in the market. Home care settings drive the growth of the infusion pump market Based on setting, the infusion pumps market has been segmented into hospitals, home care settings, ambulatory care settings, and academic & research institutes. The home care setting segment accounted for the largest share of the market in 2020. Chronic diseases, such as cancer and diabetes, require continuous monitoring and treatment. Ambulatory infusion pumps for chronic disease management enable patients to remain mobile during therapy sessions. Therefore, the use of ambulatory insulin pumps in the home and alternate care segments has increased in the recent past. Request Sample Pages :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=90374506 North America is expected to account for the highest share for players operating in the infusion pump market Geographically, the infusion pumps market is segmented into North America, Europe, APAC, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global market, followed by Europe and the APAC. The large share of North America can primarily be attributed to the high adoption of specialty infusion pumps for the treatment of chronic diseases, increasing prevalence of chronic diseases, rising geriatric population, and the presence of many large hospitals in the region. Moreover, a large number of major global players are based in the US, owing to which the US is a center for innovation in the market. The infusion pumps market is dominated by Becton, Dickinson and Company (US), Baxter International Inc. (US), B. Braun (Germany), Smiths Medical (US), Fresenius Kabi (Germany), and ICU Medical, Inc. (US). These players adopted major growth strategies such as product launches & approvals, collaborations, and expansions. Other prominent players in the market include Terumo Corporation (Japan), Nipro Corporation (Japan), Avanos Medical, Inc. (US), Tandem Diabetes Care, Inc. (US), JMS Co., Ltd. (Japan), Insulet Corporation (US), Roche Diagnostics (Switzerland), Zyno Medical (US), Teleflex, Inc. (US), Mindray Medical International Limited (China), Micrel Medical Devices SA (Greece), Ypsomed Holding AG (Switzerland), InfuTronix Solutions LLC (US), SOOIL Development Co., Ltd (South Korea), Shenzhen MedRena Biotech Co., Ltd. (China), and CODAN Medizinische Geräte GmbH & Co KG (Germany). Speak to Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=90374506 Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting Browse Related Reports: Infusion Pump Software Market by Type (DERS, Interoperability, Clinical Workflow), Indication (General Infusion, Pain & Anesthesia Management, Insulin Infusion), End User (Hospitals, Ambulatory Care Settings) - Global Forecasts to 2024https://www.marketsandmarkets.com/Market-Reports/infusion-pump-software-market-126400367.html Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021 https://www.marketsandmarkets.com/Market-Reports/insulin-delivery-device-market-107632092.html |
AuthorWe are providing and consulting the healthcare Industry Research Report. Archives
March 2022
Categories |